目标价
Search documents
Truist Securities将英伟达目标价维持在275.00美元。
Xin Lang Cai Jing· 2025-12-29 14:47
来源:滚动播报 Truist Securities将英伟达目标价维持在275.00美元。 ...
大摩:升中国银行(03988)目标价至6.3港元 评级“增持”
智通财经网· 2025-12-19 07:19
智通财经APP获悉,摩根士丹利发布研报称,根据中国银行(03988)2025年第三季度业绩,修订对该行的 盈利预测。将2025至2027年度净息差预测下调,而手续费收入预测则上调,因2025年第三季手续费收入 增长超出预期。因此,该行将中国银行2025年、2026年及2027年度净利润预测分别上调0.9%、1.4%及 1.1%,将中行目标价由5.9港元升至6.3港元,评级增持。 ...
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet
ZACKS· 2025-12-05 15:55
Profound Medical (PROF) closed the last trading session at $6.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.31 indicates an 82.4% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $2.01. While the lowest estimate of $11.00 indicates a 63% increase from the current price level, the most optimistic analyst ...
Wall Street Analysts Think Catalyst (CPRX) Could Surge 47.37%: Read This Before Placing a Bet
ZACKS· 2025-12-01 15:56
Core Viewpoint - Catalyst Pharmaceutical (CPRX) shares have increased by 10.1% over the past four weeks, closing at $23.41, with a potential upside of 47.4% based on Wall Street analysts' mean price target of $34.5 [1] Price Targets - The average price target consists of eight estimates ranging from a low of $32.00 to a high of $40.00, with a standard deviation of $2.67, indicating a potential increase of 36.7% to 70.9% from the current price [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates - Analysts are optimistic about CPRX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 8.8%, with four estimates moving higher and no negative revisions [12] Zacks Rank - CPRX currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of CPRX's potential gains, it does provide a useful guide for the direction of price movement [14]
Does Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) Have the Potential to Rally 44.43% as Wall Street Analysts Expect?
ZACKS· 2025-11-27 15:55
Core Viewpoint - Vista Energy, S.A.B. de C.V. (VIST) shows potential for significant upside, with a mean price target of $70.09 indicating a 44.4% increase from its current price of $48.53 [1] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $12.72, indicating variability among analysts [2] - The lowest estimate is $50.00, suggesting a 3% increase, while the highest estimate is $90.00, indicating an 85.5% potential surge [2] - A low standard deviation signifies strong agreement among analysts regarding price movement direction [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about VIST's earnings prospects, with a positive trend in earnings estimate revisions [11] - Over the last 30 days, one estimate has increased, leading to a 37% rise in the Zacks Consensus Estimate [12] - VIST holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research indicates they rarely predict actual stock price movements [7][10] - Analysts may set overly optimistic targets due to business incentives, which can inflate price expectations [8]
大行评级丨高盛:上调中远海控AH股目标价 上调2025至27年净利润预测
Ge Long Hui· 2025-11-05 08:34
Core Viewpoint - Goldman Sachs reports that China COSCO Shipping Holdings maintains a cautiously optimistic outlook on long-term freight rates due to over 25% of existing cargo ships being over 20 years old and needing to be scrapped between 2028 and 2030 [1] Group 1: Industry Outlook - The management highlights strong growth in cargo volume, particularly on routes in Southeast Asia, Europe, and Africa [1] - There is a noted rebound in spot freight rates in October, driven by Black Friday and the anticipated tariffs on Chinese goods leading to early shipments [1] Group 2: Financial Performance - The third-quarter earnings exceeded expectations, attributed to strong freight performance, especially in Asia routes, and better cost control compared to peers [1] - Based on the performance, net profit forecasts for 2025 to 2027 have been raised by 25% to 46%, reflecting better-than-expected third-quarter earnings and delays in port fees between China and the U.S. [1] Group 3: Target Price Adjustments - The target price for H-shares has been increased from HKD 11.5 to HKD 12.5, while the target price for A-shares has been raised from CNY 14.7 to CNY 16 [1] - The rating remains at "Neutral" [1]
CHINA COAL(1898.HK):UNATTRACTIVE DIVIDEND DESPITE DECENT QOQ GROWTH IN 3Q25
Ge Long Hui· 2025-10-30 20:41
Core Viewpoint - China Coal's earnings increased by 16% QoQ to RMB3.86 billion in 3Q25, driven by higher realized coal prices and increased olefin sales volume, but a significant drop of 53% QoQ is expected in 4Q25 due to higher costs [1][3] Financial Performance - Under CAS, earnings surged 28% QoQ to RMB4.78 billion in 3Q25, attributed to a 4% decline in unit coal production costs [2] - The average selling price (ASP) of coal rose by 7% QoQ, with both thermal and coking coal prices increasing [3] - Olefin sales volume grew by 6% QoQ, following a major production ramp-up, leading to a 28% fall in unit costs for olefin [3] Earnings Forecasts - Earnings forecasts for 2025-27 have been increased by 2-6% after adjustments, with expectations of flat earnings in the next two years despite a slight decline in average coal prices [4] - The company's H shares are projected to offer an unattractive dividend yield of 3.4-3.5% for 2025-27, with a payout ratio of 35-36% in 2023-24 [4] Valuation - The target price has been raised from HK$7.21 to HK$7.57, reflecting the increases in earnings forecasts, maintaining a target valuation of a 5% average dividend yield for 2025-27 [5]
德昌电机控股一度跌超6% 花旗指其股价上行空间有限
Zhi Tong Cai Jing· 2025-09-30 02:16
Core Viewpoint - Citi has raised its earnings forecast for DCH Holdings from 5% to 16% for the years 2024 to 2028, citing the development of liquid cooling pumps and humanoid robot joints as key drivers [1] Group 1: Stock Performance - DCH Holdings' stock price initially dropped over 6%, currently down 4.98% at HKD 41.6, with a trading volume of HKD 193 million [1] - The stock has appreciated 2.8 times this year and approximately 55% this month [1] Group 2: Earnings Forecast and Valuation - The target price for DCH Holdings has been increased from HKD 29 to HKD 45, reflecting a forecasted P/E ratio of 19 times for next year, which is 2 standard deviations above the average and the highest since 2017 [1] - The target P/E for the ordinary automotive and industrial product segments is set at 11 times, while the new business segments are projected at a P/E of 300 times [1] Group 3: Investment Rating - The investment rating has been downgraded from "Buy" to "Neutral" due to limited upside potential in the stock price [1] - The upcoming interim results are expected to show a moderate profit growth of about 10%, largely benefiting from foreign exchange factors [1]
大行评级|大摩:微升中国人寿目标价至25.7港元 上调2025至27年每股盈测
Ge Long Hui· 2025-09-19 03:53
Group 1 - Morgan Stanley updated its model following China Life's half-year performance report, raising the earnings per share estimates for 2025 to 2027 by 13.1%, 1%, and 1.9% respectively, primarily benefiting from the stock market rise and steady sales growth in the fiscal year 2025 [1] - With improvements in profit margins, the new business value forecasts for each fiscal year increased by 6.6%, 8.1%, and 8.5% respectively [1] - Morgan Stanley slightly raised the target price for China Life's H-shares from HKD 25 to HKD 25.7, maintaining an "Overweight" rating [1]
大行评级|大摩:上调银河娱乐目标价至44港元 评级“与大市同步”
Ge Long Hui· 2025-09-03 03:58
Core Viewpoint - Morgan Stanley has updated its forecast for Galaxy Entertainment, raising the dividend payout ratio prediction for 2025 to 2027 from 50% to 60%, with a 19% increase in the per-share dividend forecast [1] Financial Projections - EBITDA forecasts for 2025 to 2027 have been reduced by 1% due to higher operating expense expectations [1] - Earnings per share (EPS) forecasts have been adjusted from HKD 2.39, 2.58, and 2.73 to HKD 2.36, 2.56, and 2.72 for the respective years [1] - The target price for Galaxy Entertainment has been raised from HKD 40 to HKD 44 [1] Market Position and Outlook - The opening of the Capella Hotel is expected to help Galaxy Entertainment increase its market share [1] - Morgan Stanley has assigned a "market perform" rating, but cautions that if competitors resume dividends while Galaxy's market share remains weak, some potential premium may reverse [1]